Clinical Trials Browser

Not yet recruiting × Rectal Neoplasms × trifluridine tipiracil drug combination × Clear all

NCT06850090 2025-06-25

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

Phase 3 Not yet recruiting

Gastrointestinal

Rectal Neoplasms